Enantioselective immunorecognition of protein modification with optically active ibuprofen using polyclonal antibody

J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jun 25;806(1):11-7. doi: 10.1016/j.jchromb.2004.01.040.

Abstract

Formation of covalently bound protein adducts with 2-arylpropionic acids (2-APAs) has been proposed as a possible explanation for hypersensitivity and toxic responses to chiral carboxylic acid drugs. To identify the cellular proteins chemically modified with optically active (S)-ibuprofen, we generate polyclonal antibodies by immunizing rabbits with immunogen coupled to bovine serum albumin (BSA) via the spacer of 4-aminobutyric acid. The resulting antibodies largely cross-reacted with N-alpha-(t-butoxycarbonyl)--(S)-ibuprofenyl lysine as well as with the conjuguated (S)-ibuprofen with glycine and taurine and unconjugated (S)-ibuprofen, enabling enantioselective detection of (S)-ibuprofen residues anchored on ovalbumin molecules, introduced by the reaction of the ibuprofen p-nitrophenyl ester. Furthermore, immunoblotting with an antibody allows the enantioselective detection of (S)-ibuprofen-introduced glutathione-S-transferase (GST). These results indicate that the developed method will be useful for monitoring the generation and localization of protein covalently bound with (S)-ibuprofen, which may be the cause of ibuprofen-induced toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Antibodies / immunology*
  • Electrophoresis, Polyacrylamide Gel
  • Ibuprofen / chemistry*
  • Ibuprofen / immunology
  • Magnetic Resonance Spectroscopy
  • Molecular Sequence Data
  • Proteins / chemistry*
  • Stereoisomerism

Substances

  • Antibodies
  • Proteins
  • Ibuprofen